Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2008

View Archived Issues

PRK-124 improves symptoms of rosacea

Phase I results encouraging for diabetic foot ulcer treatment HO/03/03

CTS-1027 hepatoprotective in bile duct-ligated mice

FDA Approves Recothrom 20,000-IU vial size and co-packaging spray kit

Structural damage limited with add-on denosumab in rheumatoid arthritis patients

Biovitrum and Syntonix dose first hemophilia B patient in novel Factor IXFc trial

CombinatoRx completes enrollment in phase IIb CRx-102 trial

NycoCard CRP test to be used in major study targeting overuse of antibiotics

PsychoGenics and Roche collaborate in neuropsychiatric disorder drug discovery

DSMB recommends continuation of BioMS's MINDSET-01 trial of dirucotide in MS

AlphaRx and USAMRIID enter research and development agreement for nanobiotics

AMAG and 3SBio enter development and commercialization agreement for ferumoxytol in China

Ferring's FE-202158 prevents hypotension in experimental septic shock

Nampt inhibitor FK-866 inhibits lung tumor cell growth in vitro

New antithrombotic agents reported in recent patents

Global phase III bevacizumab and trastuzumab trial in breast cancer commences

Recent Tokuyama patent discloses novel therapeutic agents for nausea

Isotechnika presents final results of the PROMISE trial

Sapacitabine receives EMEA orphan designation for AML and MDS

Avanir reports positive outcome of pharmacokinetic study of Zenvia

Favrille reports disappointing results from phase III registration trial of Specifid in NHL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...